eli lilly glp-1 dominance launches pill, kicking off showdown with Novo Nordisk Lilly is selling $12.9 billion
Description
These data come from Cosmos, a HIPAA-defined Limited Data Set of more than 214 million patients from 218 Epic organizations including 1,235 hospitals and more than 26,800 clinics, serving patients in all 50 states and Lebanon
Once a luxury reserved for the cash-pay elite, weight-loss drugs are about to be as accessible as statinsa shift that could redefine how obesity care is delivered and challenge the direct-to-consumer playbook that made it mainstream
GLP-1 medications offer a scientifically-backed alternative, providing benefits such as: Sustained Weight Loss: Clinical studies have shown that GLP-1 therapies can lead to significant and sustainable weight loss
Next, we estimated the per-protocol effect by accounting for treatment changes and discontinuation, reflecting real-world drug exposure
Currently Available GLP-1 RAs Currently available GLP-1 RAs are summarized in TABLE 1
Do I need to follow a strict diet or workout program
